TFF Pharmaceuticals Inc.

0.07
-0.09 (-56.98%)
At close: Dec 12, 2024, 9:00 PM

TFF Pharmaceuticals Statistics

Share Statistics

TFF Pharmaceuticals has 4.44M shares outstanding. The number of shares has increased by 46.53% in one year.

Shares Outstanding 4.44M
Shares Change (YoY) 46.53%
Shares Change (QoQ) 11.88%
Owned by Institutions (%) 31.87%
Shares Floating 2.8M
Failed to Deliver (FTD) Shares 475
FTD / Avg. Volume 0.03%

Short Selling Information

The latest short interest is 171.96K, so undefined% of the outstanding shares have been sold short.

Short Interest 171.96K
Short % of Shares Out undefined%
Short % of Float 5.54%
Short Ratio (days to cover) 1.77

Valuation Ratios

The PE ratio is undefined and the forward PE ratio is -0.45. TFF Pharmaceuticals's PEG ratio is undefined.

PE Ratio undefined
Forward PE -0.45
PS Ratio 17.15
Forward PS 0.4
PB Ratio 1.32
P/FCF Ratio undefined
PEG Ratio undefined
Financial Ratio History

Enterprise Valuation

TFF Pharmaceuticals has an Enterprise Value (EV) of 7.22M.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.13, with a Debt / Equity ratio of undefined.

Current Ratio 3.13
Quick Ratio 3.13
Debt / Equity undefined
Debt / EBITDA -
Debt / FCF -
Interest Coverage undefined

Financial Efficiency

Return on Equity is -2.22% and Return on Invested Capital is -226.13%.

Return on Equity -2.22%
Return on Assets -1.77%
Return on Invested Capital -226.13%
Revenue Per Employee $38.62K
Profits Per Employee $-1.12M
Employee Count 19
Asset Turnover 0.06
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -99.12% in the last 52 weeks. The beta is 1.32, so TFF Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.32
52-Week Price Change -99.12%
50-Day Moving Average 1.37
200-Day Moving Average 2.62
Relative Strength Index (RSI) 20.19
Average Volume (20 Days) 1.45M

Income Statement

In the last 12 months, TFF Pharmaceuticals had revenue of 733.87K and earned -21.24M in profits. Earnings per share was -11.85.

Revenue 733.87K
Gross Profit 231.39K
Operating Income -21.89M
Net Income -21.24M
EBITDA -20.74M
EBIT -21.89M
Earnings Per Share (EPS) -11.85
Full Income Statement

Balance Sheet

The company has 5.48M in cash and 115.25K in debt, giving a net cash position of 5.36M.

Cash & Cash Equivalents 5.48M
Total Debt 115.25K
Net Cash 5.36M
Retained Earnings -118.33M
Total Assets 7.08M
Working Capital -432.35K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.04M and capital expenditures -94.75K, giving a free cash flow of -16.13M.

Operating Cash Flow -16.04M
Capital Expenditures -94.75K
Free Cash Flow -16.13M
FCF Per Share -9
Full Cash Flow Statement

Margins

Gross margin is 31.53%, with operating and profit margins of -2983.45% and -2894.68%.

Gross Margin 31.53%
Operating Margin -2983.45%
Pretax Margin -2894.68%
Profit Margin -2894.68%
EBITDA Margin -2826.21%
EBIT Margin -2983.45%
FCF Margin -2198.34%

Dividends & Yields

TFFP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -16928.57%
FCF Yield -5586.24%
Dividend Details

Analyst Forecast

The average price target for TFFP is $44, which is 62757.1% higher than the current price. The consensus rating is "Buy".

Price Target $44
Price Target Difference 62757.1%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Dec 19, 2023. It was a backward split with a ratio of 1:25.

Last Split Date Dec 19, 2023
Split Type backward
Split Ratio 1:25

Scores

Altman Z-Score -34.66
Piotroski F-Score 3